HRMY Competitors & Alternatives
Compare Harmony Biosciences Holdings with similar stocks in the same industry
Biotechnology
HRMY
Main Stock$34.08
Tradestie Score
65
Market Cap
$1.55B
P/E Ratio
14.2
Revenue Growth
0.2%
Analyst Upside
+30.2%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.77
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$53.63
|
$2.21B | - | 69 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$22.21
|
$2.18B | - | 66 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.96
|
$2.08B | - | 55 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.97
|
$2.02B | 44.1 | 53 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.94
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$33.41
|
$1.97B | - | 60 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.10
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$86.97
|
$1.92B | - | 53 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$72.15
|
$1.90B | 421.3 | 67 | Compare |
More HRMY Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry